Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Naive Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03088670
What this trial is testing

Efficacy and Safety of Gosogliptin as Monotherapy and in Combination With Metformin vs. Vildagliptin as Monotherapy and in Combination With Metformin in Drug-naive Type 2 Diabetic Patients.

Who this might be right for
Diabetes Mellitus, Type 2
SatRx LLC 299
Very early researchNot Yet RecruitingNCT07335094
What this trial is testing

A Clinical Study of Humanized CD19 CAR-T Cells With TLR2 for the Treatment of Adult Patients With Naive B-Cell Acute Lymphoblastic Leukemia/Lymphoma Who Are Intolerant to Intensive Chemotherapy

Who this might be right for
B Lymphoblastic Leukemia/Lymphoma
Zhujiang Hospital 60
Not applicableStudy completedNCT00700830
What this trial is testing

Observational Study to Evaluate the Safety and Efficacy of Levemir® in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 1,976
Post-approval studies (Phase 4)UnknownNCT00127777
What this trial is testing

Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in Hepatitis C Virus (HCV)-Genotype-1-Infection (PRAMA)

Who this might be right for
Hepatitis C, Chronic
University Hospital, Saarland 700
Testing effectiveness (Phase 2)Study completedNCT04452877
What this trial is testing

Dabrafenib in Combination With Trametinib in Chinese Patients With BRAF V600E Mutant Metastatic NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Novartis Pharmaceuticals 40
Post-approval studies (Phase 4)Study completedNCT00957060
What this trial is testing

Superiority of Glimepiride Over Sitagliptin in Naive Type 2 Diabetes Patients

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 400
Not applicableStudy completedNCT00963703
What this trial is testing

Treatment of TNFa Naive Patients With Poor Prognosis Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
University of Manitoba 15
Post-approval studies (Phase 4)Study completedNCT00941369
What this trial is testing

Health Assessment, Patient Treatment Satisfaction and Quality-of-Life in Insulin-Naive Type 2 Diabetes Patients

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 345
Not applicableLooking for participantsNCT06905288
What this trial is testing

Real-world Study on Secukinumab Effectiveness in Biologic-naïve Ankylosing Spondylitis (AS) Patients in Korea.

Who this might be right for
Ankylosing Spondylitis
Novartis Pharmaceuticals 70
Large-scale testing (Phase 3)UnknownNCT03535402
What this trial is testing

Measurement of the Structural Efficacy in Active RA Patients Treated With Sarilumab in Combination With MTX and Naive to Biologics

Who this might be right for
Rheumatoid Arthritis
Gaylis, Norman B., M.D. 20
Testing effectiveness (Phase 2)Study completedNCT00495677
What this trial is testing

PF-00232798 In HIV Positive Patients

Who this might be right for
HIV
Pfizer 43
Large-scale testing (Phase 3)Active Not RecruitingNCT05133531
What this trial is testing

Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria
Regeneron Pharmaceuticals 202
Post-approval studies (Phase 4)WithdrawnNCT01225705
What this trial is testing

Safety Study of Raltegravir in HIV/HCV Co-infected Patients

Who this might be right for
HIVHepatitis C
University Hospital, Bonn
Large-scale testing (Phase 3)Study completedNCT01257451
What this trial is testing

Safety and Efficacy of Galvus in Elderly Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes Mellitus
Novartis Pharmaceuticals 431
Not applicableStudy completedNCT02219945
What this trial is testing

ENOSE in Pulmonary Tuberculosis in Yogyakarta

Who this might be right for
Pulmonary Tuberculosis SuspectedOther Specified Chronic Obstructive Pulmonary DiseasePulmonary Tuberculosis TB (+) Histology, (-) Bacteriology
Tjip van der Werf 389
Testing effectiveness (Phase 2)Study completedNCT01188772
What this trial is testing

Sofosbuvir in Combination With Pegylated Interferon and Ribavirin and in Treatment-Naive Hepatitis C-infected Patients

Who this might be right for
Hepatitis C Virus
Gilead Sciences 147
Not applicableWithdrawnNCT01051544
What this trial is testing

Study of First TIME Immunotolerance Induction in Severe Hemophilia A Patients With Inhibitor at High Risk of Failure: Comparison With FVIII Concentrates With or Without Von Willebrand Factor - RES.I.S.T. Naive

Who this might be right for
Severe Hemophilia A
City of Hope Medical Center
Post-approval studies (Phase 4)Study completedNCT00145574
What this trial is testing

Efficacy and Safety of Colesevelam in Pediatric Patients With Genetic High Cholesterol

Who this might be right for
Hypercholesterolemia
Daiichi Sankyo 194
Testing effectiveness (Phase 2)Looking for participantsNCT07007052
What this trial is testing

Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Blastic Plasmacytoid Dendritic Cell Neoplasm Patients

Who this might be right for
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
French Innovative Leukemia Organisation 33
Not applicableStudy completedNCT04988178
What this trial is testing

Analysis of naïve Patients With Age-related Macular Degeneration Neovascular Type and Treated With Ranibizumab (Lucentis®) in Treat-and-extend at the CHU Brugmann.

Who this might be right for
Macular Degeneration
Brugmann University Hospital 34
Next Page